Discarding Livers From Deceased Donors: Is It Ever OK?
Jean C. Emond – 30 October 2020
Major Shifts in Outpatient Cirrhosis Care Delivery Attributable to the COVID‐19 Pandemic: A National Cohort Study
Nadim Mahmud, David S. Goldberg, David E. Kaplan, Marina Serper – 29 October 2020
Liver Transplantation and Inflammatory Bowel Disease: Breaking Barriers in a Low‐Income Country
Eric Kauffman‐Ortega, Jesus Ruiz‐Manriquez, Antonio Olivas‐Martinez, Alejandro Campos‐Murguia, Ernesto Marquez‐Guillen, Nayelli Flores‐Garcia, Mario Vilatoba, Alan Contreras‐Saldivar, Ignacio García‐Juárez – 28 October 2020
Identifying Modifiable Predictors of Long‐Term Survival in Liver Transplant Recipients With Diabetes Mellitus Using Machine Learning
Angeline Yasodhara, Victor Dong, Amirhossein Azhie, Anna Goldenberg, Mamatha Bhat – 28 October 2020 – Diabetes mellitus (DM) significantly impacts long‐term survival after liver transplantation (LT). We identified survival factors for LT recipients who had DM to inform preventive care using machine‐learning analysis. We analyzed risk factors for mortality in patients from across the United States using the Scientific Registry of Transplant Recipients (SRTR). Patients had undergone LT from 1987 to 2019, with a follow‐up of 6.47 years (standard deviation [SD] 5.95).
NAFLD: Reporting Histologic Findings in Clinical Practice
Elizabeth M. Brunt, David E. Kleiner, Danielle H. Carpenter, Mary Rinella, Stephen A. Harrison, Rohit Loomba, Zobair Younossi, Brent A. Neuschwander‐Tetri, Arun J. Sanyal, for the American Association for the Study of Liver Diseases NASH Task Force – 27 October 2020 – The role of liver biopsy in NASH has evolved along with the increased recognition of the significance of this disease, and the unmet medical need it presents. Drug development and clinical trials are rapidly growing, as are noninvasive tests for markers of steatosis, inflammation, injury, and fibrosis.
Biomarkers for Liver Fibrosis Post–Liver Transplantation: Not As Easy As It Looks
Sven M. Francque – 27 October 2020
The Impact of Dabigatran Treatment on Sinusoidal Protection Against Hepatic Ischemia/Reperfusion Injury in Mice
Daisuke Noguchi, Naohisa Kuriyama, Taemi Hibi, Koki Maeda, Toru Shinkai, Kazuyuki Gyoten, Aoi Hayasaki, Takehiro Fujii, Yusuke Iizawa, Akihiro Tanemura, Yasuhiro Murata, Masashi Kishiwada, Hiroyuki Sakurai, Shugo Mizuno – 27 October 2020 – Thrombin is a key player in the coagulation cascade, and it is attracting much attention as a promotor of cellular injured signaling. In ischemia/reperfusion injury (IRI), which is a severe complication of liver transplantation, thrombin may also promote tissue damage.
Letter to the Editor: The Limited Functions and Mechanisms of CircASAP1 as a Sponge of Onco‐microRNAs
Ye‐Zhao Wang – 26 October 2020
The Ongoing Evolution of Liver Transplantation in Alcohol‐Associated Liver Disease
John P. Rice – 24 October 2020
The Natural History of NAFLD, a Community‐Based Study at a Large Health Care Delivery System in the United States
Lisa M. Nyberg, T. Craig Cheetham, Heather M. Patton, Su‐Jau Yang, Kevin M. Chiang, Susan L. Caparosa, Julie A. Stern, Anders H. Nyberg – 24 October 2020 – Nonalcoholic fatty liver disease (NAFLD) is a global public health problem. However, the natural history of NAFLD is incomplete. This is a retrospective cohort study of patients identified with NAFLD by diagnosis codes in a large, community‐based health care delivery system.